HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
April 06, 2021 15:39 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 06, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
March 24, 2021 14:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
March 10, 2021 16:02 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...